Ipca Laboratories (BOM:524494) FFO


BOM:524494 Ipca Laboratories Ltd BOM:524494
92 GF Score
Price ₹1,780.90
GF Value ₹1,601.68
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ipca Laboratories FFO?

FFO (Funds from operations) only applies to REITs.

BOM:524494
92GF Score
Ipca Laboratories Ltd BOM:524494
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ipca Laboratories (BOM:524494) Overvalued in 2026?

Based on GuruFocus' analysis, Ipca Laboratories stock appears to be overvalued. The current stock price of ₹1,780.90 is trading 11.2% above its estimated GF Value™ of ₹1,601.68. GuruFocus considers Ipca Laboratories to be Modestly Overvalued.

Key valuation signals for BOM:524494:

  • FFO:
  • GF Value™: ₹1,601.68 vs. price of ₹1,780.90 (11.2% above fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the BOM:524494 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ipca Laboratories Business Description

Other Exchanges IPCALAB:India
Address No. 48, 123 AB, 125 & 126 Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.
92GF Score

Get the complete analysis for BOM:524494

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,780.90
Price
₹1,601.68
GF Value